C27H3308N3. It is a water-soluble compound which can be administered intravenously or intramuscularly; it quickly attains high and reliable blood concentrations and the normal intestinal flora are not much affected. After the intravenous injection of 275 mg. Reverin the initial serum concentrations are almost ten times as high as after the oral administration of 250 mg. tetracycline hydrochloride (Strauch and Koch, 1Q58) ; 8 hours later the former is still almost twice as high as the latter, and even after 24 hours therapeutic blood levels of Reverin can still be demonstrated (Finland, Purcell, Wright, Del Love, Mou, and Kass, 1954) . Dimmling, Huner, Lutzeyer, and Simon 1958) have shown that the potency and bacteriostatic range of Reverin is similar to that of tetracycline hydrochloride, but with a much lower general and local toxicity.
Because of these advantages, it has been extensively used in fulminating infections with encouraging results, and it is therefore surprising that only one previous report of its use in a case of cavernous sinus thrombosis has been found (Khare, I967) .
The usual organisms encountered in cases of cavernous sinus thrombosis are the Streptococcus, Staphylococcus, B. proteus, B. pvocyaneus, Pneumococcus, and Meningococcus (Walsh, I957) . Tempea and Gorun (I959) stated that the first two organisms were most commonly encountered, and Clune (i963) found Staphylococcus aureus (coagulase-positive) to be the most frequent.
Reverin is effective against all these organisms (Finland and others, I954), but sulphonamides and antibiotics, including broad-spectrum tetracycline and chloramphenicol, have not proved to be very effective (Table III, 
p. I I5).
Material and methods Seven cases of septic cavernous sinus thrombosis were treated with intravenous pyrrolidinomethyl tetracycline (Reverin) 275 mg. 8-hrly. Other supportive therapy, including anti-coagulants and Diamox, was added when necessary.
All the patients presented in a semiconscious or unconscious state, with high fever and neck rigidity. The clinical particulars are given in Table I . The results of the ophthalmological examination are shown patients showed lid oedema and conjunctival chemosis.
in Table II 
Comment
The most significant feature noted in the present series was that there was no evidence of residual damage in the five patients who recovered, whereas previous reports have shown morbidity rates of from 50 to 77 per cent. (Table III, opposite) .
We therefore feel that pyrrolidinomethyl tetracycline is the drug of choice in the management of septic cavernous sinus thrombosis, and that it should be administered from the start, without first trying less potent agents. Reverin in cavernous sinus thrombosis 
Summary
Pyrrolidinomethyl tetracycline (Reverin) was given intravenously in seven cases of septic cavernous sinus thrombosis, and was found to be useful in eliminating residual morbidity in the five patients who recovered.
